Skip to main content
. 2025 Feb 15;12(4):670–677. doi: 10.1093/nop/npaf021

Table 1.

Characteristics and Clinical Course of Patients With Radiation Necrosis

Patient’s number Age in years Diagnosis* Total dose [Gy] Administration of chemotherapy during radiotherapy Interval between radiotherapy and occurrence of radiation necrosis in months Location of radiation necrosis in relation to the primary tumor Symptoms Type of surgery Treatment with steroids Treatment with Avastin Recurrent tumor at further follow-up
1 58 Oligodendroglioma WHO II° 60 No 31 Local No GTR No No No
2 32 Oligodendroglioma WHO II° 54 Yes 4 Local No GTR Yes No No
3 54 Oligodendroglioma WHO II° 54 No 22 Local Yes GTR Yes No Yes
4 65 Oligodendroglioma WHO II° 54 No 6 Local No GTR No No No
5 34 Oligodendroglioma WHOII° 60 No 22.5 Distal no Partial resection Yes No No
6 67 Oligodendroglioma WHO II° 60 Yes 4 Distal Yes GTR No No No
7 67 Oligodendroglioma WHO III° 60 Yes 37 Distal No Biopsy Yes Yes Yes
8 60 Oligodendroglioma WHO III° 54 Yes 9 Local Yes GTR No No No
9 65 Oligodendroglioma WHO III° 60 No 18 Local No GTR No No No
10 28 Oligodendroglioma WHO III° 60 Yes 21 Local No GTR No No No
11 80 Glioblastoma WHO IV° 60 Yes 4 Local No GTR No No No
12 82 Glioblastoma WHO IV° 60 Yes 40 Distal No GTR No No No
13 62 Glioblastoma WHO IV° 60 Yes 4 Local No GTR No No No
14 35 Glioblastoma WHO IV 59.4 Yes 3 Distal No Partial resection Yes Yes No

*According to the 2007 World Health Organization Classification of Tumors of the Central Nervous System or its later version (2016) [9, 10]. GTR = gross total resection, Gy = gray, GTV = gross tumor volume, CTV = clinical target volume, PTV = planning target volume, Dmax = maximum dose, D0.1cm3 = dose in 0.1 cm3, VMAT = volumetric intensity-modulated arc therapy, IMRT = intensity-modulated radiation therapy, N/A = not available.